While some studies have suggested ATRA can sensitize glioma cells to chemotherapy or radiation [22,23], the specific concurrent downregulation of MGMT mRNA alongside key stemness markers in GBM cells cultured under neurosphere conditions, as observed here, adds to the understanding of ATRA’s potential multifaceted impact. The gene discussed is MGMT; the disease is glioblastoma.